Volume 17 - Issue 11 - November 2004
Heel pain is arguably the most common complaint that foot and ankle specialists hear. The majority of these complaints are linked to plantar fasciitis and we all have developed our own unique treatment algorithms for this condition. What happens when we are months into our treatment algorithm and the patient has not had much improvement or a fasciotomy has been performed and the heel pain returns? Is it still plantar fasciitis?
No. In both of these scenarios, we must revert back to our differential diagnoses. While heel pain is commonly caused by plantar
Type “DPM” or “podiatrist” into an Internet search engine and name after name of established practitioners will come up, leading to Web sites which may have established in order to market their practices. Many podiatrists have been building Web sites to supplement the traditional methods of reaching patients and facilitate the ability of potential patients to reach them.
Continuing Education »
Last year, I wrote “Extracorporeal shockwave therapy (ESWT) has a long way to go to prove it has overwhelming medical benefits that are claimed by the manufacturers, but it is still in the early stages of its evolution. With time, it will be necessary to prove these claims through prospective studies.” (See “Extracorporeal Shockwave Therapy: Hope Or Hype?,” page 46, November 2003 issue.)
While this article is not intended to prove beyond a statistical doubt that ESWT works, emerging research via prospective placebo-controlled, double-blind studie
Editor's Perspective »
There were a lot of reports circulating last month about the rise of injuries in the National Football League (NFL). An Indianapolis Star article noted that after four weeks of play, 34 players had been placed on injured reserve, the highest number in six years. As this issue went to press, 346 players are listed on injury reports in the NFL with the injuries ranging from mild to season-ending injuries. (That is an approximate average of 11 injured players per team.) Sixty-three of these injuries (18 percent) are lower-extremity injuries.
Diabetes Watch »
Ciclopirox has been well documented as a broad-spectrum antifungal agent with additional antibacterial and antiinflammatory properties.1-3 However, in recent studies reported by Linden, et al., ciclopirox has also demonstrated potent angiogenic activity, which suggests that the drug may have certain wound-healing properties.4 If this is borne out by larger studies in the future, ciclopirox may possess a significant advantage in treating fungal infections in high-risk patients.
These high-risk patients may include those who suffer fro
Diagnostic Dilemmas »
A 20-year-old male presents to your office with a painful sinus tarsi, medial arch and a history of recurrent ankle sprains over the last few years. The pain seems to limit his activities more and more, and he is frustrated with his lack of improvement. He has seen a few doctors for this problem, and has been treated with orthotics, ankle braces, physical therapy and NSAIDs. He wants to know why he is not getting better and what you can do to get him back to playing tennis.
The majority of patients who walk (or limp) into our offices have conditions that
- « Previous
- | Page 1 of 3 |
- Next »